GH treatment reduces total ghrelin in Prader-Willi syndrome (PWS) and may confound ghrelin studies in young PWS children

被引：5
|
作者：
Hauffa, Berthold P. [1 ]
Petersenn, Stephan [2 ]
机构：
[1] Univ Duisburg Essen, Univ Childrens Hosp, Dept Pediat Endocrinol & Diabetol, Essen, Germany
[2] Univ Duisburg Essen, Univ Med Ctr, Dept Endocrinol, Essen, Germany
来源：
CLINICAL ENDOCRINOLOGY | 2009年 / 71卷 / 01期
关键词：
GROWTH-HORMONE;
D O I：
10.1111/j.1365-2265.2008.03454.x
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：156 / 156
页数：1
相关论文
共 50 条
  • [41] Growth Velocity After Growth Hormone (GH) Therapy in Children with Isolated GH Deficiency (IGHD) and Prader-Willi syndrome (PWS) † 397
    Moris A Angulo
    Mariano Castro-Magaña
    Josè A Cañas
    Raul Arguello
    Roopa Karri
    Gnanagurudasan Prakasam
    Pam Vitollo
    Pediatric Research, 1998, 43 (Suppl 4) : 71 - 71
  • [42] Behavioral features in Prader-Willi syndrome (PWS): consensus paper from the International PWS Clinical Trial Consortium
    Schwartz, Lauren
    Caixas, Assumpta
    Dimitropoulos, Anastasia
    Dykens, Elisabeth
    Duis, Jessica
    Einfeld, Stewart
    Gallagher, Louise
    Holland, Anthony
    Rice, Lauren
    Roof, Elizabeth
    Salehi, Parisa
    Strong, Theresa
    Taylor, Bonnie
    Woodcock, Kate
    JOURNAL OF NEURODEVELOPMENTAL DISORDERS, 2021, 13 (01)
  • [43] Octreotide suppresses circulating ghrelin levels in children with Prader-Willi Syndrome
    Haqq, AM
    Stadler, DD
    Rosenfeld, RG
    Pratt, KL
    Frayo, S
    Cummings, DE
    Purnell, JQ
    PEDIATRIC RESEARCH, 2003, 53 (04) : 154A - 154A
  • [44] Behavioral features in Prader-Willi syndrome (PWS): consensus paper from the International PWS Clinical Trial Consortium
    Lauren Schwartz
    Assumpta Caixàs
    Anastasia Dimitropoulos
    Elisabeth Dykens
    Jessica Duis
    Stewart Einfeld
    Louise Gallagher
    Anthony Holland
    Lauren Rice
    Elizabeth Roof
    Parisa Salehi
    Theresa Strong
    Bonnie Taylor
    Kate Woodcock
    Journal of Neurodevelopmental Disorders, 2021, 13
  • [45] Prader-Willi syndrome: A model for understanding the ghrelin system
    Tauber, Maithe
    Coupaye, Muriel
    Diene, Gwenaelle
    Molinas, Catherine
    Valette, Marion
    Beauloye, Veronique
    JOURNAL OF NEUROENDOCRINOLOGY, 2019, 31 (07)
  • [46] Elevated plasma ghrelin levels in Prader-Willi syndrome
    Cummings, DE
    Clement, K
    Purnell, JQ
    Vaisse, C
    Foster, KE
    Frayo, RS
    Schwartz, MW
    Basdevant, A
    Weigle, DS
    NATURE MEDICINE, 2002, 8 (07) : 643 - 644
  • [47] Distal arthrogryposis and neonatal hypotonia: An unusual presentation of Prader-Willi Syndrome (PWS)
    Denizot S.
    Boscher C.
    Le Vaillant C.
    Rozé J.C.
    Gras Le Guen C.
    Journal of Perinatology, 2004, 24 (11) : 733 - 734
  • [48] Final height in Prader-Willi syndrome (PWS) children treated with recombinant growth hormone (rhGH)
    Angulo, MA
    Castro-Magana, MS
    Canas, JA
    Arguello, R
    Lamerson, M
    Tapiador, C
    Appiagyei, Y
    PEDIATRIC RESEARCH, 2000, 47 (04) : 237A - 237A
  • [49] Diagnostic testing for Prader-Willi Syndrome (PWS) and Angelman Syndrome (AS) a cost comparison.
    Wiktor, A
    Monaghan, KG
    Van Dyke, DL
    AMERICAN JOURNAL OF HUMAN GENETICS, 2001, 69 (04) : 210 - 210
  • [50] BMI changes and metabolic factors in children with Prader Willi syndrome (PWS)
    Nyunt, Ohn
    Archbold, Sinead M.
    Donnelly, Jennifer M.
    Cotterill, Andrew M.
    Harris, Mark
    Leong, Gary M.
    HORMONE RESEARCH, 2009, 72 : 296 - 296
12345